Growth and glucocorticoids in children with kidney disease.
Glucorticoid therapy inhibits statural growth. Alternate-day therapy causes less growth suppression than does daily therapy, and, in experimental animals and children with asthma, it has been associated with normal growth. Although catch-up growth may occur after cessation of steroid therapy, this is not always the case, especially when therapy has been prolonged. In children treated with steroids for glomerulonephritis or nephrotic syndrome and especially in children after renal transplantation, factors other than steroid therapy may contribute to growth retardation. Steroids may suppress growth by direct action on cell metabolism, by inhibition of growth hormone or somatomedin and/or by effects on calcium and phosphorus metabolism. Present knowledge of mechanisms of action and dose-response relationships is complete, and it is difficult to prescribe therapy which will achieve a predictable therapeutic effect without inhibiting growth.
D000818:Animals; D002675:Child, Preschool; D003864:Depression, Chemical; D004334:Drug Administration Schedule; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006128:Growth / Q000187:drug effects; D006130:Growth Disorders / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000188:drug therapy*; D016030:Kidney Transplantation; D008297:Male; D008954:Models, Biological; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014184:Transplantation, Homologous
D005938:Glucocorticoids; D011241:Prednisone